Article info

PDF
ROCK inhibitors for the treatment of ocular diseases

Authors

  • Ramin Nourinia Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Shintaro Nakao Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Souska Zandi Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik am Lindenhofspital, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Sare Safi Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Ali Hafezi-Moghadam Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hamid Ahmadieh Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Dr. Hamid Ahmadieh, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran; hahmadieh{at}hotmail.com
View Full Text

Citation

Nourinia R, Nakao S, Zandi S, et al
ROCK inhibitors for the treatment of ocular diseases

Publication history

  • Received 22 February 2017
  • Revised 10 July 2017
  • Accepted 22 July 2017
  • Published online 9 August 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.